Hims Hers Health Inc stock is traded at $22.94, with a volume of 48,114,546. It is down -11.77% in the last 24 hours and down -25.81% over the past month. Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Previous Close:
$26.00
Open:
$25.25
24h Volume:
48,114,546
Relative Volume:
3.28
Market Cap:
$5.35B
Revenue:
$2.35B
Net Income/Loss:
$128.37M
P/E Ratio:
43.94
EPS:
$0.5221
Net Cash Flow:
$57.42M
1W Performance:
-9.11%
1M Performance:
-25.81%
6M Performance:
-18.85%
1Y Performance:
-44.09%
1-Day Range:
$22.73$25.67
1-Week Range:
$22.73$28.66
52-Week Range:
$13.74$42.70
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health IncSector
HealthcarePhone
415-851-0195Address
2269 CHESTNUT ST, SAN FRANCISCO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS